Which has higher earnings & valuation, TRLS or IQAI?

IQ-AI has higher revenue and earnings than Trellus Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Trellus Health £359K 1.44 -£7.98M -£5.00 N/A IQ-AI £538.19K 3.30 N/A N/A N/A

Is TRLS or IQAI more profitable?

IQ-AI has a net margin of -77.52% compared to Trellus Health's net margin of -6,826.32%. Trellus Health's return on equity of -49.78% beat IQ-AI's return on equity. Company Net Margins Return on Equity Return on Assets Trellus Health -6,826.32% -49.78% -22.76% IQ-AI -77.52% -140.75% -22.03%

Do analysts rate TRLS or CRW?

Craneware has a consensus price target of GBX 1,673.33, suggesting a potential upside of 54.65%. Given Craneware's stronger consensus rating and higher possible upside, analysts clearly believe Craneware is more favorable than Trellus Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Trellus Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Craneware 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00

Which has preferable valuation and earnings, TRLS or CRW?

Craneware has higher revenue and earnings than Trellus Health. Trellus Health is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Trellus Health £359K 1.44 -£7.98M -£5.00 N/A Craneware £205.96M 1.80 £14.27M £56.00 19.32

Trellus Health (TRLS) Competitors

GBX 0.12 0.00 (0.00%)

As of 10/7/2026

Compare

TRLS vs. IQAI, DVRG, SENS, EMIS, and CRW

Should you buy Trellus Health stock or one of its competitors? Trellus Health's main competitors and comparable companies include IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), and Craneware (CRW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Trellus Health compare to IQ-AI?

Trellus Health (LON:TRLS) and IQ-AI (LON:IQAI) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment, valuation and dividends.

IQ-AI has higher revenue and earnings than Trellus Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Trellus Health	£359K	1.44	-£7.98M	-£5.00	N/A
IQ-AI	£538.19K	3.30	N/A	N/A	N/A

1.6% of Trellus Health shares are held by institutional investors. 9.6% of Trellus Health shares are held by insiders. Comparatively, 66.0% of IQ-AI shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

IQ-AI has a net margin of -77.52% compared to Trellus Health's net margin of -6,826.32%. Trellus Health's return on equity of -49.78% beat IQ-AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Trellus Health	-6,826.32%	-49.78%	-22.76%
IQ-AI	-77.52%	-140.75%	-22.03%

In the previous week, Trellus Health's average media sentiment score of 0.00 equaled IQ-AI'saverage media sentiment score.

Company	Overall Sentiment
Trellus Health	Neutral
IQ-AI	Neutral

Trellus Health has a beta of 2.509, suggesting that its stock price is 151% more volatile than the broader market. Comparatively, IQ-AI has a beta of 2.25, suggesting that its stock price is 125% more volatile than the broader market.

Summary

IQ-AI beats Trellus Health on 5 of the 9 factors compared between the two stocks.

How does Trellus Health compare to DeepVerge?

Trellus Health (LON:TRLS) and DeepVerge (LON:DVRG) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, valuation, profitability, analyst recommendations, dividends, earnings and institutional ownership.

Trellus Health has a beta of 2.509, suggesting that its stock price is 151% more volatile than the broader market. Comparatively, DeepVerge has a beta of 1.07, suggesting that its stock price is 7% more volatile than the broader market.

DeepVerge has a net margin of -19.81% compared to Trellus Health's net margin of -6,826.32%. DeepVerge's return on equity of -10.27% beat Trellus Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Trellus Health	-6,826.32%	-49.78%	-22.76%
DeepVerge	-19.81%	-10.27%	-5.56%

In the previous week, Trellus Health's average media sentiment score of 0.00 equaled DeepVerge'saverage media sentiment score.

Company	Overall Sentiment
Trellus Health	Neutral
DeepVerge	Neutral

DeepVerge has higher revenue and earnings than Trellus Health. Trellus Health is trading at a lower price-to-earnings ratio than DeepVerge, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Trellus Health	£359K	1.44	-£7.98M	-£5.00	N/A
DeepVerge	£12.41M	0.00	-£2.46M	-£0.01	N/A

1.6% of Trellus Health shares are held by institutional investors. Comparatively, 4.2% of DeepVerge shares are held by institutional investors. 9.6% of Trellus Health shares are held by insiders. Comparatively, 9.5% of DeepVerge shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

DeepVerge beats Trellus Health on 7 of the 10 factors compared between the two stocks.

How does Trellus Health compare to Sensyne Health?

Sensyne Health (LON:SENS) and Trellus Health (LON:TRLS) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, analyst recommendations, media sentiment, institutional ownership and earnings.

Sensyne Health has a net margin of 0.00% compared to Trellus Health's net margin of -6,826.32%. Sensyne Health's return on equity of 0.00% beat Trellus Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sensyne Health	N/A	N/A	N/A
Trellus Health	-6,826.32%	-49.78%	-22.76%

In the previous week, Sensyne Health's average media sentiment score of 0.00 equaled Trellus Health'saverage media sentiment score.

Company	Overall Sentiment
Sensyne Health	Neutral
Trellus Health	Neutral

1.6% of Trellus Health shares are owned by institutional investors. 9.6% of Trellus Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Sensyne Health has higher revenue and earnings than Trellus Health. Trellus Health is trading at a lower price-to-earnings ratio than Sensyne Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sensyne Health	£7.81M	0.00	N/A	-£22.10	N/A
Trellus Health	£359K	1.44	-£7.98M	-£5.00	N/A

Summary

Sensyne Health beats Trellus Health on 5 of the 8 factors compared between the two stocks.

How does Trellus Health compare to EMIS Group?

Trellus Health (LON:TRLS) and EMIS Group (LON:EMIS) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, analyst recommendations, valuation, profitability, risk, institutional ownership and media sentiment.

EMIS Group has a net margin of 17.23% compared to Trellus Health's net margin of -6,826.32%. EMIS Group's return on equity of 23.17% beat Trellus Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Trellus Health	-6,826.32%	-49.78%	-22.76%
EMIS Group	17.23%	23.17%	7.99%

In the previous week, Trellus Health's average media sentiment score of 0.00 equaled EMIS Group'saverage media sentiment score.

Company	Overall Sentiment
Trellus Health	Neutral
EMIS Group	Neutral

Trellus Health has a beta of 2.509, indicating that its share price is 151% more volatile than the broader market. Comparatively, EMIS Group has a beta of -0.13, indicating that its share price is 113% less volatile than the broader market.

1.6% of Trellus Health shares are owned by institutional investors. Comparatively, 105.6% of EMIS Group shares are owned by institutional investors. 9.6% of Trellus Health shares are owned by company insiders. Comparatively, 3.6% of EMIS Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

EMIS Group has higher revenue and earnings than Trellus Health. Trellus Health is trading at a lower price-to-earnings ratio than EMIS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Trellus Health	£359K	1.44	-£7.98M	-£5.00	N/A
EMIS Group	£176.86M	0.00	£30.48M	£0.47	N/A

Summary

EMIS Group beats Trellus Health on 8 of the 10 factors compared between the two stocks.

How does Trellus Health compare to Craneware?

Trellus Health (LON:TRLS) and Craneware (LON:CRW) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership.

Trellus Health has a beta of 2.509, meaning that its stock price is 151% more volatile than the broader market. Comparatively, Craneware has a beta of 0.28, meaning that its stock price is 72% less volatile than the broader market.

Craneware has a consensus price target of GBX 1,673.33, suggesting a potential upside of 54.65%. Given Craneware's stronger consensus rating and higher possible upside, analysts clearly believe Craneware is more favorable than Trellus Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Trellus Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Craneware	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Craneware has higher revenue and earnings than Trellus Health. Trellus Health is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Trellus Health	£359K	1.44	-£7.98M	-£5.00	N/A
Craneware	£205.96M	1.80	£14.27M	£56.00	19.32

1.6% of Trellus Health shares are held by institutional investors. Comparatively, 32.6% of Craneware shares are held by institutional investors. 9.6% of Trellus Health shares are held by insiders. Comparatively, 1.2% of Craneware shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Craneware had 1 more articles in the media than Trellus Health. MarketBeat recorded 1 mentions for Craneware and 0 mentions for Trellus Health. Trellus Health's average media sentiment score of 0.00 beat Craneware's score of -0.55 indicating that Trellus Health is being referred to more favorably in the media.

Company	Overall Sentiment
Trellus Health	Neutral
Craneware	Negative

Craneware has a net margin of 9.58% compared to Trellus Health's net margin of -6,826.32%. Craneware's return on equity of 5.94% beat Trellus Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Trellus Health	-6,826.32%	-49.78%	-22.76%
Craneware	9.58%	5.94%	2.28%

Summary

Craneware beats Trellus Health on 13 of the 16 factors compared between the two stocks.

Get Trellus Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TRLS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

TRLS vs. The Competition

Export

Metric	Trellus Health	Healthcare Technology Industry	Healthcare Sector	LON Exchange
Market Cap	£516K	£1.80B	£7.19B	£2.79B
Dividend Yield	N/A	3.97%	2.53%	6.21%
P/E Ratio	-0.02	21.58	274.66	367.15
Price / Sales	1.44	95.02	579.54	88,471.92
Price / Cash	0.76	31.89	76.82	27.89
Price / Book	0.01	6.26	10.95	6.96
Net Income	-£7.98M	-£19.09M	£3.50B	£5.89B
7 Day Performance	N/A	-1.66%	-1.82%	-0.20%
1 Month Performance	N/A	-0.10%	-6.33%	-0.66%
1 Year Performance	-86.13%	-22.66%	3.09%	22.17%

Trellus Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TRLS Trellus Health	N/A	GBX 0.12 flat	N/A	N/A	£516K	£359K	N/A	31
IQAI IQ-AI	N/A	GBX 0.80 flat	N/A	+0.0%	£1.77M	£538.19K	N/A	6	Gap Up
DVRG DeepVerge	N/A	N/A	N/A	N/A	£1.14M	£12.41M	N/A	73
SENS Sensyne Health	N/A	N/A	N/A	N/A	£583K	£7.81M	N/A	70	Gap Down
EMIS EMIS Group	N/A	N/A	N/A	N/A	£1.23B	£176.86M	4,085.11	1,560

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:TRLS) was last updated on 10/9/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trellus Health (TRLS) Competitors

TRLS vs. IQAI, DVRG, SENS, EMIS, and CRW

How does Trellus Health compare to IQ-AI?

Summary

How does Trellus Health compare to DeepVerge?

Summary

How does Trellus Health compare to Sensyne Health?

Summary

How does Trellus Health compare to EMIS Group?

Summary

How does Trellus Health compare to Craneware?

Summary

New MarketBeat Followers Over Time

TRLS vs. The Competition

Trellus Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Trellus Health (TRLS) Competitors

TRLS vs. IQAI, DVRG, SENS, EMIS, and CRW

How does Trellus Health compare to IQ-AI?

Which has higher earnings & valuation, TRLS or IQAI?

Do insiders and institutionals hold more shares of TRLS or IQAI?

Is TRLS or IQAI more profitable?

Does the media prefer TRLS or IQAI?

Which has more volatility & risk, TRLS or IQAI?

Summary

How does Trellus Health compare to DeepVerge?

Which has more volatility and risk, TRLS or DVRG?

Is TRLS or DVRG more profitable?

Does the media favor TRLS or DVRG?

Which has better valuation and earnings, TRLS or DVRG?

Do institutionals & insiders have more ownership in TRLS or DVRG?

Summary

How does Trellus Health compare to Sensyne Health?

Is SENS or TRLS more profitable?

Does the media prefer SENS or TRLS?

Do insiders and institutionals believe in SENS or TRLS?

Which has preferable valuation and earnings, SENS or TRLS?

Summary

How does Trellus Health compare to EMIS Group?

Is TRLS or EMIS more profitable?

Does the media favor TRLS or EMIS?

Which has more volatility & risk, TRLS or EMIS?

Do insiders & institutionals believe in TRLS or EMIS?

Which has higher valuation and earnings, TRLS or EMIS?

Summary

How does Trellus Health compare to Craneware?

Which has more risk and volatility, TRLS or CRW?

Do analysts rate TRLS or CRW?

Which has preferable valuation and earnings, TRLS or CRW?

Do institutionals and insiders have more ownership in TRLS or CRW?

Does the media prefer TRLS or CRW?

Is TRLS or CRW more profitable?

Summary

New MarketBeat Followers Over Time

TRLS vs. The Competition

Trellus Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools